Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ES-SCLC”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Large-scale testing (Phase 3)Looking for participantsNCT06712355
What this trial is testing

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
BioNTech SE 621
Testing effectiveness (Phase 2)Study completedNCT01057342
What this trial is testing

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT06812260
What this trial is testing

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Shanghai Henlius Biotech 26
Early research (Phase 1)Study completedNCT03085849
What this trial is testing

SGI-110 Plus Durvalumab/Tremelimumab in SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Catherine Shu 2
Large-scale testing (Phase 3)Active Not RecruitingNCT05468489
What this trial is testing

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 200
Early research (Phase 1)Looking for participantsNCT05787587
What this trial is testing

PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more
IDEAYA Biosciences 216
Testing effectiveness (Phase 2)Looking for participantsNCT06663098
What this trial is testing

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Gruppo Oncologico Italiano di Ricerca Clinica 142
Not applicableActive Not RecruitingNCT06008353
What this trial is testing

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

Who this might be right for
Extensive-stage Small-cell Lung Cancer
AstraZeneca 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06211036
What this trial is testing

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Who this might be right for
Extensive-Stage Small-Cell Lung CancerSmall-Cell Lung Cancer
Amgen 563
Testing effectiveness (Phase 2)Looking for participantsNCT05623319
What this trial is testing

Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
SCLC,Extensive Stage
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06441344
What this trial is testing

Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell

Who this might be right for
SCLCMaintenance Treatment
Taizhou Hospital 136
Not applicableLooking for participantsNCT07070011
What this trial is testing

Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Chest Hospital of Shanghai Jiao Tong University 38
Testing effectiveness (Phase 2)Looking for participantsNCT06477523
What this trial is testing

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Sichuan University 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT06961201
What this trial is testing

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy
Changchun GeneScience Pharmaceutical Co., Ltd. 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562337
What this trial is testing

SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06909383
What this trial is testing

Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Cancer - Associated Anorexia - Cachexia Syndrome
Guangzhou Institute of Respiratory Disease 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07141264
What this trial is testing

Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

Who this might be right for
SCLC,Extensive Stage
Tang-Du Hospital 32
Testing effectiveness (Phase 2)UnknownNCT04363255
What this trial is testing

First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
Taizhou Hospital 20
Early research (Phase 1)Study completedNCT05116007
What this trial is testing

Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Akeso 35
Load More Results